Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-08-21Clinical Trial Update: Study for Evaluating Different Methods of Measuring Depression Treatment Response [NA]
Pfizer-sponsored clinical trial completed that evaluates different methods for measuring response to depression treatment.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental ANDA for Fluoxetine by Teva Pharmaceuticals USA, Inc., authorizing a generic version of fluoxetine. The action f…
-
FDA approval · 2008-08-15FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
The FDA approved the original ANDA for bupropion hydrochloride from Actavis Pharma, Inc., enabling a generic product to reach the market. Th…
-
CLINICAL_TRIALS trial_result · 2008-08-15Clinical Trial Update: Light Therapy for Elderly Depression [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating light therapy for elderly patients with major depressive disorder has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-08-14FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-08-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., a generic antidepressant.
-
FDA approval · 2008-08-13FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Citalopram from Torrent Pharmaceuticals Limited.
-
FDA approval · 2008-08-13FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc., granting approval of an updated or …
-
FDA approval · 2008-08-13FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for trazodone hydrochloride (generic) under ANDA 071524.
-
FDA label_change · 2008-08-11FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) submitted by AstraZeneca Pharmaceuticals LP. This approval results in l…
-
FDA approval · 2008-08-11FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for trazodone hydrochloride from Apotex Corp, enabling a generic version to be marketed for the …
-
FDA approval · 2008-08-11FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for trazodone hydrochloride (Apotex Corp). The approval pertains to a supplemental filing updating t…
-
CLINICAL_TRIALS trial_result · 2008-08-07Clinical Trial Update: The Therapeutic Efficacy of Neurofeedback in Depression [NA]
A completed clinical trial from Korea University evaluated the therapeutic efficacy of neurofeedback for depression.
-
CLINICAL_TRIALS trial_result · 2008-07-28Clinical Trial Update: Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro [Phase 4]
Phase 4 trial evaluating Ambien CR (zolpidem tartrate extended-release) for insomnia associated with depression when used with Lexapro (esci…
-
FDA approval · 2008-07-16FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental abbreviated new drug application (ANDA) for sertraline from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals …
-
CLINICAL_TRIALS trial_result · 2008-07-14Clinical Trial Update: Fluoxetine vs. Brief Psychotherapy for Major Depression [NA]
A completed clinical trial compared fluoxetine with brief psychotherapy for adults with Major Depressive Disorder.
-
FDA approval · 2008-07-14FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved Lannett's supplemental application for doxepin hydrochloride, confirming a generic version is approvable. The product will carr…
-
FDA approval · 2008-07-10FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC under ANDA077415.
-
FDA approval · 2008-07-09FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL, resulting in modifications to labeling/indications for the product.
-
CLINICAL_TRIALS trial_result · 2008-07-08Clinical Trial Update: Improving Chronic Disease Care With PatientSite [NA]
A completed clinical trial evaluating PatientSite to improve chronic disease care in patients with depression and chronic pain.
-
FDA approval · 2008-07-02FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for sertraline hydrochloride (generic sertraline), authorizing the a…
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for citalopram from Hikma Pharmaceuticals USA, resulting in an approved addition to the product's au…
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Citalopram hydrobromide from Aurobindo Pharma Limited, enabling continued marketing of this …
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram (citalopram hydrobromide) from Aurobindo Pharma Limited.